Welcome to our dedicated page for AINOS SEC filings (Ticker: AIMDW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ainos, Inc. (AIMDW) SEC filings page provides access to regulatory documents that describe the company’s capital structure, warrant listing, and material events affecting its AI and SmellTech business. AIMDW represents warrants to purchase Ainos common stock, which are listed on The Nasdaq Stock Market LLC, and the company reports developments related to these securities and its common stock through current reports on Form 8-K and other filings.
In its SEC disclosures, Ainos identifies itself as a Texas corporation with Commission File Number 001-41461. Filings detail actions such as an At The Market Offering Agreement for issuing common stock through a placement agent, including prospectus supplements that adjust the aggregate offering amount. Other documents describe a 1-for-5 reverse stock split of the company’s common stock, effective June 30, 2025, with the stock trading on a split-adjusted basis on Nasdaq from that date and cash in lieu of fractional shares.
Form 8-K reports also cover topics such as changes in the company’s independent registered public accounting firm, strategic orders and partnerships for AI Nose deployment in semiconductor manufacturing, and the furnishing of earnings press releases. These filings help explain how Ainos is financing its operations, managing its audit relationships, and formalizing commercial agreements around its AI Nose and SmellTech-as-a-Service platform.
On Stock Titan, Ainos filings are supplemented with AI-powered summaries that highlight key points from lengthy documents, making it easier to understand the implications of items like capital raises, reverse splits, or partnership announcements. Users can quickly review 8-Ks related to AIMDW and AIMD, and connect those disclosures to the company’s broader strategy in AI-powered scent digitization and its dual-platform AI and biotech model.
Form 8-K – Item 8.01 Other Events
On 6-Aug-2025, Ainos, Inc. (Nasdaq: AIMD; AIMDW) reported that it has secured a US$2.1 million order from ASE Technology Holding Co., Ltd. to deploy the company’s AI Nose sensing platform in a semiconductor manufacturing environment. The related press release is provided as Exhibit 99.1.
The filing contains no revisions to previously issued financial statements, no earnings guidance, and no additional contractual terms beyond the order’s value and intended use. Other than standard cover information, Items 8.01 and 9.01 are the only sections with substantive disclosure.
ASE Test Inc, a 10% owner of Ainos Inc (AIMD), reported a significant insider transaction on June 23, 2025. The company acquired 29,476 shares of common stock through a Share Exchange Agreement with Taiwan Carbon Nano Technology Corporation.
Key transaction details:
- Acquired shares in exchange for 5,687,109 ordinary shares of Ainos Inc. (Cayman Islands)
- Exchange value approximately $0.497 per share
- Total beneficial ownership following transaction: 58,887 shares
- Ownership form: Direct through ASE Test, indirect through ASE Technology Holding Co., Ltd
This Form 4 filing indicates a strategic share exchange transaction that increases ASE Test's stake in Ainos Inc. The transaction was executed through a formal agreement dated June 3, 2025, demonstrating continued institutional investment interest in the company.
Ainos announced a strategic partnership with Kenmec Mechanical Engineering through an 8-K filing dated June 24, 2025. The company, listed on the Nasdaq Stock Market under symbols AIMD (common stock) and AIMDW (warrants), made this material disclosure in accordance with SEC regulations.
Key details from the filing:
- The partnership agreement is legally binding, though specific terms were not disclosed in the 8-K
- The announcement was made via press release, included as Exhibit 99.1
- The filing was signed by CEO Chun-Hsien Tsai
- Company headquarters: 8880 Rio San Diego Drive, San Diego, CA
This strategic alliance could represent a significant business development for Ainos, potentially impacting its operational capabilities and market position, though investors should refer to the full press release for detailed partnership terms and implications.
Director Chun-Jung Tsai of Ainos reported multiple sales of common stock in June 2025:
- June 18: Sold 5,000 shares at $0.5217 per share
- June 19: Sold 10,903 shares at $0.5517 per share
- June 23: Sold 10,000 shares at $0.50 per share
Following these transactions, Tsai directly owns 1,401,997 shares of common stock, representing a reduction of 25,903 shares from their previous position. The sales occurred at prices ranging from $0.50 to $0.5517 per share, with a total value of approximately $13,900. These insider sales may indicate the director's personal portfolio management decisions or views on the company's valuation.